UNIPROT_AC,Autoinhibitory element,Target element,Relief mechanism
Q7XEK4,2-68 (N-terminal autoinhibitory region),439-812 (ATPase domain),Partner binding(Calmodulin)
Q12774,1093-1100 (Autoinhibitory helix),1174-1358 (DH domain),PTM (Phosphorylation of autoinhibitory helix)
A0A044RE18,42-116 (Prodomain),159-447 (Kexin/furin catalytic domain),Cleavage (Cleavage of prodomain at the RRKR motif)
Q39253,1-36 (N-terminal regulatory region),56-62 (7 amino acids within the first quarter of CAX1),PTM (Phosphorylation of Ser25); Partner binding (Binding of regulatory protein to N-terminal regulatory region)
Q5VT25,658-930 (Coiled-coil domains),77-343 (Protein kinase domain),Ligand binding (phorbol 12-myristate 13-acetate (PMA) binding)
O15078,1-580 (N-terminal autoinhibitory region),1966-2479 (C-terminal autoinhibitory region),Partner binding (CP110 binding to membrane-binding domain)
O15078,1966-2479 (C-terminal autoinhibitory region),1-580 (N-terminal autoinhibitory region),Partner binding (CP110 binding to membrane-binding domain)
Q9JK25,1258-1314 (C-terminal zinc knuckle domains),60-278 (CAP-Gly domain),Others (Binding of CLIP-170 to microtubules)
Q8K382,527-547 (C-terminal autoinhibitory region),1-406 (DENN domain),PTM (Akt-mediated phosphorylation in autoinhibitory region) 
P48608,114-369 (DID domain),59-241 (GBD domain),Partner binding (Binding of GTP-bound Rho proteins to DID domain)
P48608,991-1051 (DAD domain),59-241 (GBD domain),Partner binding (Binding of GTP-bound Rho proteins to DID domain)
Q9FJJ5,265-293 (C-terminal tail),1-120 (CH domain),Partner binding (Binding of plus end-tracking proteins to the EB1B tail
C8ZE58,604-741 (Autoinhibitory region),855-886 (Transactivation domain),Ligand binding (Binding of alpha-isopropylmalate)
P41971,152-209 (N-terminal inhibitory domain),1-89 (Ets domain),PTM (Phosphorylation of C-terminal domain by MAP kinase)
O88933,339-372 (PF/PN motif),1-68 (N-terminal extension),Partner binding (Binding of SH3 or WW domain-containing proteins to PF/PN motif)
A2A5C2,1-42 (N-terminal autoinhibitory region),334-417 (ETS domain),Partner binding (Binding of RUNX1 to ETS domain)
A2A5C2,417-480 (C-terminal autoinhibitory region),334-417 (ETS domain),Partner binding (Binding of RUNX1 to ETS domain)
O94532,353-406  (DID domain),759-1199 (FH2 domain),Partner binding (Cdc42p binding to DID domain)
O94532,1391-1419 (DAD domain),759-1199 (FH2 domain),Partner binding (Bud6p binding in the vicinity of DAD domain)
Q9VUC6,125-373 (GBD and DID domains),687-1132 (FH2 domain),Partner binding (Cdc42 binding to GBD domain)
Q9VUC6,1136-1169 (DAD domain),687-1132 (FH2 domain),Partner binding (Binding of activated GTPase)
P13508,1174-1295 (Negative regulatory domain),797-858 (RAM domain); 886-1168 (Ankyrin repeats),
P04521,289-307 (Negatively charged linker),1-200 (Nuclease domain),Partner binding (Rad50 binding to RBD)
P04521,308-339 (RBD),1-200 (Nuclease domain),Partner binding (Rad50 binding to  RBD)
A0A544CH04,112-139 (KOW domain),1-101 (NGN-like domain),Partner binding (Recruitment to a transcription elongation complex)
O75037,929-1010 (Regulatory coiled-coil domain),6-378 (Kinesin motor domain),
Q16720,1093-1124 (C-terminal segment/Calmodulin binding domain),354-1060 (P-type ATPase domain),Partner binding (Calmodulin binding to C-terminal segment); Ligand binding (Acidic phospholipid binding to AL region)
Q8IZQ8,1-149 (MHD domain and linker),700-938 (TAD domain),Others (D130A and E135A mutations)
Q6H1V1,356-362 (Autoinhibitory domain),1-486 (Bestrophin),Ligand binding (Ca2+ binding to Best3)
Q04584,100-267 (Proline-rich region); Partner binding (VASP binding to proline-rich region),352-538 (LIM domains),PTM (Phosphorylation within proline-rich region)
Q04584,352-538 (LIM domains),100-267 (Proline-rich region),PTM (Phosphorylation of S142 by Akt); Partner binding (VASP binding to proline-rich region)
Q9HES9,895-927 (tail),9-342 (Kinesin motor domain),Partner binding (Cargo-adapter binding)
A1X283,368-427 (Third SH3 domain),5-129 (PX domain),PTM (Tks4 phosphorylation)
Q95UN8,56-120 (SH3 domain),485-487 (PVP motif within the LZ-CRIB linker),Partner binding (Rac or Msn binding)
Q6I750,39-134 (MANEC domain),241-295 (Kunitz domain 1),Partner binding (SPD domain of matriptase to Kunitz domain 1 of HAI-1)
Q6I750,308-366 (365-linker),241-295 (Kunitz domain 1),Partner binding (SPD domain of matriptase to Kunitz domain 1 of HAI-1)
Q6I750,367-420 (Kunitz domain 2),241-295 (Kunitz domain 1),Partner binding (CUB domain of matriptase to Kunitz domain 2)
P27715,1035-1084 (C1 domain),1471-1954 (MUN domain),Ligand binding (Diacylglycerol (DAG) or calcium binding to C2B)
P27715,1140-1268 (C2B domain),1471-1954 (MUN domain),Ligand binding (Diacylglycerol (DAG) or calcium binding to C2B)
P27715,1269-1470 (C2B-MUN linker region),1471-1954 (MUN domain),Ligand binding (Diacylglycerol (DAG) or calcium binding to C2B)
Q8IZM6,256-260 (DDYGD motif),186-189 (PRR motif),Partner binding (Mek2 binding)
Q8IZM6,388-433 (C-terminal tail),186-189 (PRR motif),PTM (JNK1-mediated phosphorylation at Ser424)
Q9P2E2,764-772 (CC2 segment),3-343 (Kinesin motor domain),
Q9P2E2,847-1029 (C-terminal tail),3-343 (Kinesin motor domain),Partner binding (Cargo protein binding to the C-terminal tail)
A9QM74,1-92 (importin-beta-binding domain),102-495 (NLS-binding domain comprising armadillo (Arm) repeats),Partner binding (importin-beta binding)
P10105,385-410 (Hexapeptide),505-569 (Homeodomain),Partner binding (EXD binding to the hexapeptide of LAB)
P45442,175-183 (EGF-like repeat),103-169 (DSL domain),Ligand binding (Membrane association of TM domain)
P45442,204-215 (EGF-like repeat),103-169 (DSL domain),Ligand binding (Membrane association of TM domain)
P45442,233-265 (EGF-like repeat),103-169 (DSL domain),Ligand binding (Membrane association of TM domain)
P45442,308-402 (Intracellular domain),103-169 (DSL domain),Ligand binding (Membrane association of TM domain)
Q9Y6R4,253-553 (Autoinhibitory region),1343-1601 (Protein kinase domain),Partner binding (GADD45 protein binding to a site near the inhibitory domain)
Q62073,1-22 (N-terminal autoinhibitory region),36-291 (Protein kinase domain),Ligand binding (TGF-beta binding); Partner binding (bone morphogenetic protein binding)
Q12851,466-670 (Leucine-rich domains),16-273 (Protein kinase domain),Partner binding (perhaps binding of regulatory proteins to the C-terminal tail)
P49138,318-338 (Autoinhibitory A-helix),5-311 (Protein kinase domain),PTM (Phosphorylation at Thr-317)
O54992,308-350 (Putative autoinhibitory   -helix),22-304 (Protein kinase domain),PTM (Phosphorylation at Thr-182 by p38 MAPK)
P10911,286-348 (Autoinhibitory region),687-811 (PH domain),Cleavage (Truncation of an N-terminal autoinhibitory region)
Q06413,279-367 (Linker),"1-61 (Transcription factor, MADS-box)",PTM (Phosphorylation of T80 in the MADS/MEF2 domain)
Q06413,368-399 (Transcription repressor domain),"1-61 (Transcription factor, MADS-box)",PTM (Phosphorylation of T80 in the MADS/MEF2 domain)
P29294,964-992 (Autoinhibitory pseudosubstrate),696-951 (Protein kinase domain),Partner binding (CaM binding)
Q6PDN3,787-806 (Autoinhibitory pseudosubstrate),1486-1741 (Protein kinase domain),Partner binding (CaM binding)
Q9HC98,108-114 (Tyrosine motif),31-41 (N-terminal extension of kinase domain),Partner binding (Interaction with C-terminal domain of Nek9)
O88942,"170-183 (Serine-rich region, SRR)",267-269 (NLS),PTM (Dephosphorylation of phosphoserines in SRR)
Q8N5V2,175-182 (Autoinhibitory helix),273-457 (DH domain),PTM (Phosphorylation at a Tyr residue in the autoinhibitory helix by Src)
Q80TM9,No autoinhibitory elements,,
Q2LKW6,625-709 (Leucine-rich repeat),126-435 (NACHT domain),Cleavage (Cleavage by anthrax lethal toxin (LeTx) endopeptidase)
Q8K3Z0,658-1019 (Leucine-rich repeats),6-185 (CARD domains),Partner binding (Binding with NALP1 and caspase-1)
Q9HC29,786-1009 (Leucine-rich repeats),26-218 (CARD domains),Partner binding (Binding with NALP1 and caspase-1
Q9NQ66,518-533 (the ordered region of X/Y linker),316-656 (TIM barrel),Partner binding (Binding of heterotrimeric G proteins and Ras-like GTPases)
P51178,444-487 (X/Y linker),316-656 (TIM barrel),Partner binding (Binding of heterotrimeric G proteins and Ras-like GTPases)
Q9NES8,15-155 (N-terminal tetratricopeptide repeat domains),156-495 (Phosphatase domain),Partner binding (Binding of Hsp90 to the TPR domain)
Q09137,285-349 (Autoinhibitory region),25-297 (Catalytic kinase domain),Ligand binding (AMP binding); PTM (Phosphorylation at Thr-172 by CaMKK  )
P00515,93-97 (Autoinhibitory segment),136-256 (Cyclic nucleotide-binding domain),Ligand binding (cAMP binding)
P31322,111-115 (Autoinhibitiory segment),154-274 (Cyclic nucleotide-binding domain),Ligand binding (cAMP binding)
Q15139,422-543 (PH domain),583-839 (Protein kinase domain),PTM (Phosphorylation at Tyr-463 by Abl)
Q94527,640-738 (Ankyrin domain),147-446 (RHD); 452-457 (Nuclear localization signal),Cleavage (Endoproteolytic cleavage)
O94955,420-611 (C-terminal BTB domain),1-220 (GTPase domain),Partner binding (Rab9 binding to BTB domain)
Q9UR24,6-16 (Leucine-latch motif),273-498 (ATPase),"Others (DNA damage, Interaction of C-terminal region with N-terminal region)"
Q9N5D3,244-448  (DH domain),893-1165 (Ras guanine-nucleotide exchange factors catalytic domain),Partner binding (Ras binding to allosteric site)
Q9N5D3,496-606  (PH domain),893-1165 (Ras guanine-nucleotide exchange factors catalytic domain),Ligand binding (PIP2 binding to the PH domain)
Q9N5D3,1067-1493  (C-terminal docking segment),893-1165 (Ras guanine-nucleotide exchange factors catalytic domain),Partner binding (Binding of Grb2 to this segment)
Q96N96,98-206 (ABR-SH3 domain),561-652 (C-terminal tail),Partner binding (APC binding to ABR)
G4SLH0,16206-16264 (Autoinhibitory sequence),15934-16189 (Protein kinase domain),Others (Probably mechanical stress)
Q15942,61-346 (Proline-rich region),384-570 (LIM domains),PTM (Phosphorylation within proline-rich region)
Q15942,384-570 (LIM domains),61-346 (Proline-rich region),PTM (Phosphorylation within proline-rich region)
Q93107,91-157 (PAN domain),469-725 (Protein kinase domain),Partner binding (Binding of Rac around CRIB domain)
Q9DG15,1-228 (N-terminal part including GAP domain and ankyrin repeats),257-347 (C-terminal SHD domain),Partner binding (Binding of paxillin and liprin-   to PBS domain); PTM (Phosphorylation at Ser-709 within PBS domain)
P42685,42-110 (SH3 domain),234-491 (Protein kinase domain),Partner binding (Binding of SH2 domain of SAP to SH3)
P42685,114-208 (SH2 domain),234-491 (Protein kinase domain),Partner binding (Probable binding of phosphorylated SLAM(CD150) to SH2 domain)
P42685,209-233 (SH2-CD linker),234-491 (Protein kinase domain),
P42685,492-505 (C-terminal regulatory tail),234-491 (Protein kinase domain),PTM (Dephosphorylation of Tyr residue)
Q7TNR9,1-46 (SH3 domain),78-262 (DH domain),Partner binding (APC binding to CAB motif adjacent to SH3 domain)
P67999,424-525 (Autoinhibitory domain),91-352 (Protein kinase domain),PTM (Phosphorylation of Ser within this domain stimulated by Cdk5)
O60282,916-928 (tail),6-335 (Kinesin motor domain),Partner binding (Cargo-adapter binding)
O70481,1499-1757 (C-terminal fragment),1-1031 (N-terminal region containing three substrate-binding sites),Ligand binding (Binding of dipeptides with destabilizing N-terminal residues)
P04409,36-86 (C1A domain),341-583 (Protein kinase domain),Ligand binding (phorbol esters or diacylglycerol to C1A domain)
P04409,101-151 (C1B domain),341-583 (Protein kinase domain),Ligand binding (phorbol esters or diacylglycerol to C1B domain)
P04409,152-177 (C1B-C2 linker),341-583 (Protein kinase domain),
P04409,159-242 (C2 domain),341-583 (Protein kinase domain),Ligand binding (Ca2+ binding to C2 domain)
Q65CL1,1-259 (N-terminal region),260-626 (Middle region),Others (Stretch of middle region by actomyosin-generated force)
A0A377U130,"1-56 (Region I, activator interacting domain)","108-477 (Region III, DNA binding domain)",Partner binding (activator binding)
B1MTB0,186-215 (D/E repeats),8-163 (HMG boxes),PTM (Phosphorylation at the repeats)
